Bytul Mokaddesur Rahman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bytul Mokaddesur Rahman has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Adeeba Jaheen Faruqui1 shared publication
Ashraf Ali
Department of Pharmacy, Faculty of Life Science, Mawlana Bhashani Science and Technology University, Bangladesh
1 shared publicationElias Al-Mamun
Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Dhaka, Bangladesh
1 shared publication- Fatema- Tuz- Zohora
University of Asia Pacific
1 shared publication Israt Zerin Alam
Department of Pharmacy, Faculty of Science, University of Rajshahi, Bangladesh
1 shared publication- Israt Zerin Alam
Department of Pharmacy, Faculty of Science, University of Rajshahi, Rajshahi-6205, Bangladesh
1 shared publication
Latest Publications
- Open Access
- 1 January 2025
- Published by MedCrave Group Kft. in MOJ Public Health
- Vol. 14 (1) , 45-50
A longitudinal study reflecting a pandemic-driven revolution of telemedicine in Bangladesh with promising prospects
COVID-19 has been a public health crisis for quite a long time worldwide. Providing primary health care during this has proven to be quite difficult. Telemedicine played an imperative part in this by minimizing virus spread and utilizing the time of healthcare experts. This survey was designed to know about the prevalence of telemedicine during Covid-19 pandemic as well as its future prospect in Bangladesh. Four stakeholders were categorized for the study: common people, physicians, pharmaceutical professionals and regulatory body. Data was collected both via online and offline. Among the general people, 50.23% took health services through telemedicine service during the pandemic and 24.64% before the pandemic. Both general people (78.88%) and physicians (60%) expressed their satisfaction regarding the service. 93% pharmaceutical professionals also suggested that telemedicine should be implemented in all hospitals. Among the service takers 100% people were prescribed cold medicines. 58% of the respiratory issues were addressed through telemedicine. Physicians as well as regulatory authority considered raising awareness about telemedicine to be an important factor. Therefore, telemedicine should be utilized in several ways in our health sector. The post-Covid-19 era presents a unique opportunity for Bangladesh to harness the potential of telemedicine in addressing healthcare disparities and improving access to quality care. While challenges persist, strategic investments, technological innovation, and policy support can ensure that telemedicine becomes a cornerstone of a more equitable and efficient healthcare system in Bangladesh.
- 1 January 2025
- Published by MedCrave Group Kft. in MOJ Public Health
- Vol. 14 (1) , 45-50
Open AccessA longitudinal study reflecting a pandemic-driven revolution of telemedicine in Bangladesh with promising prospects
COVID-19 has been a public health crisis for quite a long time worldwide. Providing primary health care during this has proven to be quite difficult. Telemedicine played an imperative part in this by minimizing virus spread and utilizing the time of healthcare experts. This survey was designed to know about the prevalence of telemedicine during Covid-19 pandemic as well as its future prospect in Bangladesh. Four stakeholders were categorized for the study: common people, physicians, pharmaceutical professionals and regulatory body. Data was collected both via online and offline. Among the general people, 50.23% took health services through telemedicine service during the pandemic and 24.64% before the pandemic. Both general people (78.88%) and physicians (60%) expressed their satisfaction regarding the service. 93% pharmaceutical professionals also suggested that telemedicine should be implemented in all hospitals. Among the service takers 100% people were prescribed cold medicines. 58% of the respiratory issues were addressed through telemedicine. Physicians as well as regulatory authority considered raising awareness about telemedicine to be an important factor. Therefore, telemedicine should be utilized in several ways in our health sector. The post-Covid-19 era presents a unique opportunity for Bangladesh to harness the potential of telemedicine in addressing healthcare disparities and improving access to quality care. While challenges persist, strategic investments, technological innovation, and policy support can ensure that telemedicine becomes a cornerstone of a more equitable and efficient healthcare system in Bangladesh.
- 3 April 2024
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 19 (2) , 1-13
In Vitro Profiling of Gliclazide-Loaded Aerosil 380 Solid Dispersion–Based Tablets with Co-Processed Excipients
- 3 April 2024
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 19 (2) , 1-13
In Vitro Profiling of Gliclazide-Loaded Aerosil 380 Solid Dispersion–Based Tablets with Co-Processed Excipients